Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Study demonstrates cross-neutralization among SARS-CoV-2 Omicron sublineages

Researchers assessed the cross-neutralization among three sublineages of the SARS-CoV-2 Omicron variant: BA.1, BA.2, and BA.3 sublineages, and an additional strain, USA/WA1-2020 (wild-type) in mice.

5 Apr 2022

Recombinant fragment of the lectin-binding region of Gal-3BP stimulates the expression of IL-6 in SARS-CoV-2 sensitive cells

A recent study investigated the impact of a recombinant fragment of cellular glycoprotein Gal-3BP on IL-6 expression in acute COVID-19.

5 Apr 2022

“MixOmicron” SARS-CoV-2 recombinant evades variant screening

A new study describes a new variant that resembles the SARS-CoV-2 Omicron BA.21 for the most part but has a small segment at the 3’ tip that belongs to the BA.1 variant.

5 Apr 2022

Effectiveness of COVID-19 vaccines against hospitalization in those testing positive for Omicron and Delta variants

A recent study assessed the effectiveness of SARS-CoV-2 vaccines against the hospitalization of infected patients.

5 Apr 2022

Study generates a picture of the myocardial transcriptional landscape of COVID-19

Researchers profiled cardiac tissue transcriptomes of COVID-19 patients.

5 Apr 2022

Study detects SARS-CoV-2 BA.1/BA.2 recombinant in two epidemiologically linked cases

Researchers have focussed on detecting BA.1/BA.2 recombinant in travelers through surveillance.

5 Apr 2022

Direction and magnitude of predictors of all-cause mortality following hospitalization with influenza, RSV, or SARS-CoV-2

Researchers performed a retrospective cohort study to identify predictors of mortality following hospitalization with influenza, respiratory syncytial virus, or SARS-CoV-2.

5 Apr 2022

Prior COVID vaccination induces a more robust antibody response to Omicron

A recent study posted to the medRxiv* preprint server assessed the impact of prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination on the human immune response against SARS-CoV-2 Omicron infection.

5 Apr 2022

Framework for genomic surveillance of SARS-CoV-2 Mpro evolution

A recent study posted to the bioRxiv* preprint server investigated the active genetic evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (Mpro), its emerging mutations, and the existence of antiviral resistance against Mpro inhibitors like paxlovid.

5 Apr 2022

Study on the efficacy of a BNT162b2 booster dose in the elderly

In a recent study posted to the medRxiv* preprint server, researchers characterized the immune responses against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Omicron variant after receiving a booster dose of BNT162b2 vaccine in older people.

5 Apr 2022

Pandemic to endemic: downside risks of widespread SARS-CoV-2 transmission

In a recent study posted to the medRxiv* preprint server, researchers evaluated the impact of changes in infection fatality rate (IFR), intrinsic reproductive number (R0), and the durability of immunity on the annual coronavirus disease 2019 (COVID-19) death toll in the United States (US). This study demonstrated the risks of abiding by the ‘live with the disease’ COVID-19 mitigation strategy.

4 Apr 2022

Air surveillance of SARS-CoV-2 and other respiratory pathogens

A recent study posted to the medRxiv* preprint server reported severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) detection in air samples from real-world congregate settings.

4 Apr 2022

The SAVE initiative to monitor the impact of SARS-CoV-2 variants

The SAVE initiative assesses the impact of SARS-CoV-2 variants on diagnostics, vaccines, and therapies, as well as communicating public health dangers.

4 Apr 2022

BNT162b2 booster vaccine provides equal protection against BA.1 and BA.2

Researchers compare the neutralization of BA.1 and BA.2 strains in immunized people who had received two doses and a booster BNT162b2 mRNA vaccine.

4 Apr 2022

What are the long-term symptoms of SARS-CoV-2 infection?

Researchers determines whether some symptoms of long-COVID are more specifically associated with SARS-CoV-2 infection than other conditions.

4 Apr 2022

How sleep and mental health were affected in Sweden during the COVID-19 pandemic

Researchers uncovered the relationship between mental health and sleep in Sweden during the SARS-CoV-2 pandemic.

4 Apr 2022

Magnitude and durability of SARS-CoV-2 S-binding antibody titers in the pre-variant era among healthcare workers in NYC

Researchers analyzed sera samples of 400 participants of the PARIS study to evaluate the risk of SARS-CoV-2 infection and seroreversion for an average of 84 days.

4 Apr 2022

Study investigates targeted phenotyping of host proteins aiding drug repurposing in COVID-19

Researchers conducted selective phenotyping of coronavirus disease 2019 -relevant host proteins to facilitate target identification for drug repurposing.

4 Apr 2022

The emergence and limited spread of the Mu SARS-CoV-2 variant

A recent report provides insights into the restricted worldwide spread of the SARS-CoV-2 Mu (B.1.621) variant.

4 Apr 2022

SARS-CoV-2 prevalence during the initial period of SARS-CoV-2 Omicron variant emergence in Finland

A recent study presented the rapid spike in COVID-19 seroprevalence during the emergence of the Omicron variant in Finland.

4 Apr 2022

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Study demonstrates cross-neutralization among SARS-CoV-2 Omicron sublineages

Recombinant fragment of the lectin-binding region of Gal-3BP stimulates the expression of IL-6 in SARS-CoV-2 sensitive cells

“MixOmicron” SARS-CoV-2 recombinant evades variant screening

Effectiveness of COVID-19 vaccines against hospitalization in those testing positive for Omicron and Delta variants

Study generates a picture of the myocardial transcriptional landscape of COVID-19

Study detects SARS-CoV-2 BA.1/BA.2 recombinant in two epidemiologically linked cases

Direction and magnitude of predictors of all-cause mortality following hospitalization with influenza, RSV, or SARS-CoV-2

Prior COVID vaccination induces a more robust antibody response to Omicron

Framework for genomic surveillance of SARS-CoV-2 Mpro evolution

Study on the efficacy of a BNT162b2 booster dose in the elderly

Pandemic to endemic: downside risks of widespread SARS-CoV-2 transmission

Air surveillance of SARS-CoV-2 and other respiratory pathogens

The SAVE initiative to monitor the impact of SARS-CoV-2 variants

BNT162b2 booster vaccine provides equal protection against BA.1 and BA.2

What are the long-term symptoms of SARS-CoV-2 infection?

How sleep and mental health were affected in Sweden during the COVID-19 pandemic

Magnitude and durability of SARS-CoV-2 S-binding antibody titers in the pre-variant era among healthcare workers in NYC

Study investigates targeted phenotyping of host proteins aiding drug repurposing in COVID-19

The emergence and limited spread of the Mu SARS-CoV-2 variant

SARS-CoV-2 prevalence during the initial period of SARS-CoV-2 Omicron variant emergence in Finland

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in